These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18586489)

  • 1. Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.
    Park JJ; Lee JH; Ghosh SC; Bricard G; Venkataswamy MM; Porcelli SA; Chung SK
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3906-9. PubMed ID: 18586489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.
    Raju R; Castillo BF; Richardson SK; Thakur M; Severins R; Kronenberg M; Howell AR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4122-5. PubMed ID: 19535248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A specific ligand of V alpha 14 NKT cells and its presentation].
    Harada M; Taniguchi M
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
    [No Abstract]   [Full Text] [Related]  

  • 4. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
    Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
    J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of NBD-alpha-galactosylceramide and its immunologic properties.
    Sakai T; Ehara H; Koezuka Y
    Org Lett; 1999 Aug; 1(3):359-61. PubMed ID: 10822576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of diglycosylceramides and evaluation of their iNKT cell stimulatory properties.
    Liu Y; Deng S; Bai L; Freigang S; Mattner J; Teyton L; Bendelac A; Savage PB
    Bioorg Med Chem Lett; 2008 May; 18(10):3052-5. PubMed ID: 18206371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.
    Veerapen N; Brigl M; Garg S; Cerundolo V; Cox LR; Brenner MB; Besra GS
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4288-91. PubMed ID: 19502056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.
    Fujio M; Wu D; Garcia-Navarro R; Ho DD; Tsuji M; Wong CH
    J Am Chem Soc; 2006 Jul; 128(28):9022-3. PubMed ID: 16834361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry.
    Park JJ; Lee JH; Seo KC; Bricard G; Venkataswamy MM; Porcelli SA; Chung SK
    Bioorg Med Chem Lett; 2010 Feb; 20(3):814-8. PubMed ID: 20061147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
    Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.
    Liang PH; Imamura M; Li X; Wu D; Fujio M; Guy RT; Wu BC; Tsuji M; Wong CH
    J Am Chem Soc; 2008 Sep; 130(37):12348-54. PubMed ID: 18712867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation.
    Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.